Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms
Brian K. Link, Sheri A. Kostelny, Michael S. Cole, William P. Fusselman, J. Yun Tso, George J. WeinerVolume:
77
Année:
1998
Langue:
english
Pages:
6
DOI:
10.1002/(sici)1097-0215(19980717)77:23.0.co;2-e
Fichier:
PDF, 107 KB
english, 1998